GlassScriptPhysician profile
Kovid Trivedi
NPI 1033406566
$74,863.57
in general payments reported to CMS, 2019-2025
45 companies · $35K in 2025
The $35K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,288 · 2020: $1,084 · 2021: $678 · 2022: $2,374 · 2023: $9,362 · 2024: $25K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Travel and Lodging: $8,954 · Food and Beverage: $8,424 · Consulting Fee: $6,060 · Education: $2,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,297.00 |
| Travel and Lodging | $8,953.62 |
| Food and Beverage | $8,424.12 |
| Consulting Fee | $6,060.00 |
| Education | $2,706.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $50,984.77 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Genzyme Corporation | $7,236.78 | 2019-2025 | |
| Intuitive Surgical, INC. | $6,633.54 | 2022-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Noah Medical Corporation | $2,087.17 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,072.31 | 2019-2025 | Ofev |
| Glaxosmithkline, LLC. | $1,272.03 | 2019-2025 | Nucala, Trelegy Ellipta |
| Ethicon INC. | $657.59 | 2022 | |
| Covidien LP | $608.21 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $522.88 | 2024-2025 | Dupixent |
| United Therapeutics Corporation | $515.96 | 2021-2025 | Tyvaso, Remodulin, Orenitram |
| Genentech USA, INC. | $223.65 | 2019-2023 | Xolair |
| Actelion Pharmaceuticals US, INC. | $206.77 | 2019-2022 | |
| Grifols USA, LLC | $170.81 | 2019-2023 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $143.29 | 2019-2024 | Zerbaxa, Recarbrio, Dificid |
| Insmed, INC. | $133.97 | 2019-2023 | Arikayce |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $115.08 | 2025 | Ohtuvayre |
| Novartis Pharmaceuticals Corporation | $105.74 | 2019-2024 | |
| Sunovion Pharmaceuticals INC. | $99.09 | 2019 | |
| Sanofi-Aventis U.S. LLC | $97.99 | 2025 | |
| Philips North America LLC | $79.06 | 2023-2024 | (Ak6) Vest Therapy |
| Avadel Cns Pharmaceuticals, LLC | $77.13 | 2023-2024 | Lumryz |
| Gilead Sciences, INC. | $74.86 | 2019-2022 | |
| Amgen INC. | $69.51 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.67 | 2019-2024 | |
| Baxter Healthcare | $62.92 | 2022-2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Mylan Specialty L.P. | $56.68 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $48.95 | 2022-2023 | |
| Shire North American Group INC | $40.57 | 2019 | |
| La Jolla Pharmaceutical Company | $39.30 | 2021-2022 | |
| Pulmonx Corporation | $38.87 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Takeda Pharmaceuticals U.S.A., INC. | $33.77 | 2020-2021 | |
| Regeneron Pharmaceuticals, INC. | $30.87 | 2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $30.50 | 2024 | Voquezna |
| Harmony Biosciences LLC | $29.87 | 2022-2024 | |
| Axsome Therapeutics, INC. | $29.48 | 2023 | Sunosi |
| Itamar Medical INC | $28.18 | 2025 | Watchpatone |
| Pfizer INC. | $26.57 | 2019-2023 | |
| Covis Pharma Gmbh | $20.59 | 2022 | |
| Foundation Medicine, INC. | $15.86 | 2023 | |
| Circassia INC. | $14.70 | 2019 | |
| Sandoz INC. | $13.64 | 2024 | Treprostinil |
| Mallinckrodt Enterprises LLC | $13.05 | 2019 | |
| Eusa Pharma (US) LLC | $12.75 | 2020 | |
| Veran Medical Technologies, INC. | $11.91 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kovid Trivedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.